Question from Deputy Ken O’Flynn - PQ 39834-26
Deputy O'Flynn asked about the reimbursement of omaveloxolone (skyclarys) for individuals with Friedreich's ataxia. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (skyclarys) for individuals with Friedreich's ataxia. Read the HSE response.
Deputy Graves asked about the measures being taken to encourage greater participation in the dental treatment scheme in north County Dublin.
Deputy O'Flynn asked about the average period between European Medicines Agency authorisation and final reimbursement decision for orphan medicines.
Deputy O'Flynn asked about the Irish reimbursement assessment process for omaveloxolone (Skyclarys®). Read the HSE response.
Deputy Nolan asked about the waiting lists for scoliosis treatment and spinal surgery for children in the midlands. Read the HSE response.
Deputy O'Flynn asked about the waiting list for HSE substance misuse service operating in HSE South West. Read the HSE response.
Deputy Ó Murchú asked about the staffing budget allocation for Our Lady of Lourdes Hospital, Drogheda from 2024 to 2026. Read the HSE response.
Deputy Bennett asked about the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA). Read the HSE response.
Deputy O'Flynn asked if the HSE maintains regional service demand projections for addiction services. Read the HSE response.
Deputy O'Flynn asked about vacancy levels within Children's Disability Network Teams (CDNTs). Read the HSE response.